Bristol Myers Squibb BMS has issued a pointed demand for the NHS to fund a greater share of pharmaceutical innovation calling for the UK to pay what it describes as
All posts tagged in pharmaceuticals2- Page
46Articles
Novo Nordisk, headquartered in Copenhagen, has seen its shares surge by more than 6 per cent after unveiling promising results from a late-stage clinical trial of its new anti-obesity tablet.
GSK, one of Britain’s foremost pharmaceutical giants, has announced an ambitious plan to invest $30 billion in the United States over the coming five years. This investment will bolster research
The United Kingdom is facing a stark decline in its attractiveness to global investors in the life sciences and pharmaceutical industries, with industry leaders warning the nation is falling behind
Britain faces a growing crisis in its life sciences sector as a senior executive at Novartis has declared the UK “uninvestable” owing to stringent and outdated drug pricing policies. Johan
Eli Lilly, one of the world’s largest pharmaceutical companies, has temporarily halted orders of its highly sought-after weight-loss injection, Mounjaro, to the UK. This move comes as the market braces
Brussels and Washington have unveiled the specifics of a major EU-US trade agreement, delivering a considerable boon to Ireland’s pharmaceutical sector. Under the terms, the United States will impose a
Wes Streeting, the new health secretary, has escalated his confrontation with leading pharmaceutical firms over the soaring cost of medicines and its impact on the UK’s broader life sciences sector.
The UK market for private weight loss drugs is bracing itself for seismic change as Eli Lilly announces dramatic price increases for its popular Mounjaro injections. Over 1.5 million Britons
Shares in Novo Nordisk climbed over five per cent on the Copenhagen exchange after the Danish pharmaceuticals firm received crucial approval from the United States Food and Drug Administration for
A new oral medication weight loss, orforglipron, has shown promising results in a landmark trial, marking a significant step for obesity treatment in the UK. Developed by Eli Lilly, orforglipron
Shares in European drug companies slumped to a four-month low on Wednesday, after US President Donald Trump reiterated his intention to impose tariffs on pharmaceutical imports in a bid to
Alzheimers patients can extend cognitive health for years with breakthrough drugs ||| Groundbreaking trial results have revealed that radical new treatments can effectively stall the progression of Alzheimer’s disease for
AstraZeneca has reported record second quarter revenues, propelled by robust oncology sales and expansion in the United States, surpassing City expectations. The pharmaceutical company’s total revenue rose by 11 per
A breakthrough in the battle against Alzheimer’s disease may be on the horizon after promising trial results revealed the potential of an innovative drug developed by Roche. Trontinemab has delivered
AstraZenecas chief executive has described the pharmaceutical giant as a very American company following rising speculation about a potential shift of its main stock market listing from London to New
